GO:0039692 single stranded viral RNA replication via double stranded DNA intermediate: Retroviral Replication Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0039692 describes a viral replication strategy in which a single-stranded RNA genome is converted into double-stranded DNA, integrated into host chromatin, and transcribed by host RNA polymerase II.
• This process is characteristic of retroviruses and pararetroviruses such as hepatitis B virus (HBV), where the reverse transcription step is a key therapeutic target.
• The reverse transcriptase enzyme, encoded by the virus, is essential for synthesizing dsDNA from the ssRNA template.
• Integration of the dsDNA intermediate into the host genome is a hallmark of retroviral replication and can lead to persistent infection and oncogenesis.
• Studying GO:0039692 provides insights into viral persistence, immune evasion, and the development of antiviral drugs and gene therapy vectors.
• CRISPR-based knockout, knock-in, and point mutation models are powerful tools to dissect the host and viral factors involved in this replication pathway.
Description
GO:0039692, single stranded viral RNA replication via double stranded DNA intermediate, is a biological process that defines the replication cycle of retroviruses and pararetroviruses, including human immunodeficiency virus (HIV) and hepatitis B virus (HBV). In this process, the viral genomic RNA is first reverse transcribed into double-stranded DNA (dsDNA) by a virus-encoded reverse transcriptase. The resulting dsDNA then integrates into the host chromosomal DNA, where it serves as a template for transcription by host RNA polymerase II, producing new viral RNA genomes and messenger RNAs. This replication strategy is unique among RNA viruses and is a critical determinant of viral persistence and pathogenesis. Understanding GO:0039692 is essential for researchers studying viral replication, host-pathogen interactions, and the development of antiviral therapies. The reverse transcription step is a major target for nucleoside analogs and non-nucleoside inhibitors used to treat HIV and HBV infections. Moreover, the integration of viral dsDNA into the host genome can disrupt cellular genes, leading to oncogenesis, as seen in HBV-associated hepatocellular carcinoma. The process also has biotechnological applications, as retroviral vectors are widely used for gene delivery in gene therapy and cell engineering. Recent advances in CRISPR gene editing and high-throughput sequencing have enabled detailed dissection of the host factors and viral elements that regulate GO:0039692. For example, studies on HBV covalently closed circular DNA (cccDNA) have revealed mechanisms of viral persistence and reactivation. Similarly, research on adeno-associated virus (AAV) RNA processing has shed light on how viral transcripts are regulated. These findings underscore the importance of GO:0039692 in both basic virology and translational research.
single stranded viral RNA replication via double stranded DNA intermediate At A Glance
| GO ID | GO:0039692 |
|---|---|
| GO term | single stranded viral RNA replication via double stranded DNA intermediate |
| Ontology | biological_process |
| Synonym | retroviral genome replication, viral ssRNA replication via dsDNA intermediate |
| Major function | Replication of viral RNA genomes through a dsDNA intermediate that integrates into the host genome and is transcribed by host RNA polymerase II. |
| Viral families | Retroviridae (e.g., HIV), Hepadnaviridae (e.g., HBV), and pararetroviruses. |
| Key enzyme | Reverse transcriptase (RT), encoded by the virus. |
| Host dependency | Requires host RNA polymerase II for transcription of integrated provirus. |
| Disease relevance | AIDS, hepatitis B, hepatocellular carcinoma, and retroviral vector safety. |
What Is GO:0039692?
GO:0039692 is defined as a viral genome replication process in which the template is single-stranded RNA (ssRNA), and replication proceeds via a double-stranded DNA (dsDNA) intermediate. The viral genomic RNA is first reverse transcribed into dsDNA, which then integrates into the host chromosomal DNA. Subsequently, the integrated DNA is transcribed by host RNA polymerase II to produce new viral RNA molecules.
Why Is single stranded viral RNA replication via double stranded DNA intermediate Important in Cell Biology?
GO:0039692 is fundamentally important because it describes the replication mechanism of major human pathogens, including HIV and HBV, which cause millions of infections worldwide. The reverse transcription and integration steps are targets for life-saving antiviral drugs, and the integrated provirus can persist for the lifetime of the host cell, complicating cure strategies. Additionally, this process is exploited in gene therapy vectors, where safety and efficacy depend on controlled reverse transcription and integration. Understanding the host factors and viral determinants of GO:0039692 is therefore critical for developing novel therapeutics and improving gene delivery technologies.
• HIV and HBV rely on this replication strategy, causing AIDS and chronic hepatitis, respectively.
• Reverse transcriptase inhibitors are cornerstone therapies for HIV and HBV, validating the pathway as a drug target.
• Integration of viral dsDNA can cause insertional mutagenesis, leading to oncogenesis, as seen in HBV-related liver cancer.
• The process is essential for the life cycle of retroviral vectors used in CAR-T cell therapy and gene therapy.
• Studying GO:0039692 helps explain viral latency and reactivation, key barriers to curing HIV and HBV.
• Host factors involved in reverse transcription and integration are potential targets for host-directed antivirals.
• The pathway is a model for understanding RNA-to-DNA information flow, with implications for genome evolution.
• CRISPR screens can identify host dependency factors for this process, revealing new therapeutic targets.
• Quantification of viral dsDNA intermediates, such as HBV cccDNA, is used to monitor treatment response.
• The process is relevant to emerging viruses and zoonotic transmissions, as seen with retroviruses.
What Happens During single stranded viral RNA replication via double stranded DNA intermediate?
Reverse Transcription of Viral RNA into Double-Stranded DNA
In simple terms: The virus converts its RNA genome into DNA using a viral enzyme called reverse transcriptase.
The first step in GO:0039692 is the reverse transcription of the single-stranded viral RNA genome into a double-stranded DNA (dsDNA) copy. This reaction is catalyzed by the viral reverse transcriptase, which possesses RNA-dependent DNA polymerase, DNA-dependent DNA polymerase, and RNase H activities. For HBV, the reverse transcription occurs within the viral capsid, using a protein primer and a specific RNA template called pregenomic RNA. The resulting dsDNA is then either integrated into the host genome or, in the case of HBV, converted into covalently closed circular DNA (cccDNA) in the nucleus. This step is a major target for antiviral drugs such as tenofovir and lamivudine.
Integration of Viral dsDNA into the Host Genome
In simple terms: The newly made viral DNA inserts itself into the host cell's DNA, becoming a permanent part of the cell's genetic material.
Following reverse transcription, the viral dsDNA is transported into the nucleus and integrated into the host chromosomal DNA. This integration is mediated by the viral integrase enzyme in retroviruses, while HBV integration occurs via a less defined mechanism that often involves host DNA repair pathways. Integration is not sequence-specific but shows preferences for active transcription units. Once integrated, the viral DNA is referred to as a provirus (for retroviruses) or as integrated HBV DNA. This step is critical for the establishment of persistent infection and is a key difference between retroviruses and other RNA viruses.
Transcription of Integrated Viral DNA by Host RNA Polymerase II
In simple terms: The integrated viral DNA is read by the host cell's transcription machinery to produce new viral RNA.
The integrated viral DNA serves as a template for transcription by the host RNA polymerase II. This enzyme recognizes viral promoters and enhancers located in the long terminal repeats (LTRs) of retroviruses or in the viral regulatory regions of HBV. The resulting transcripts include full-length genomic RNA, which will be packaged into new virions, and spliced subgenomic RNAs that encode viral proteins. For HBV, transcription of cccDNA produces pregenomic RNA and subgenomic RNAs. The efficiency of transcription is influenced by host transcription factors and the chromatin environment of the integration site.
Assembly and Release of New Viral Particles
In simple terms: New viral RNA and proteins are assembled into particles that bud from the cell to infect other cells.
After transcription, the viral genomic RNA is exported to the cytoplasm, where it is packaged into new viral particles along with viral structural proteins and enzymes. For retroviruses, assembly occurs at the plasma membrane, and particles bud off in a process that requires host ESCRT machinery. For HBV, assembly occurs in the endoplasmic reticulum and requires the viral core protein and surface antigens. The newly formed virions then undergo maturation, which may involve further processing of the viral proteins, and are released to infect new cells. This step completes the replication cycle and is essential for viral spread.
Key Genes Involved in GO:0039692 single stranded viral RNA replication via double stranded DNA intermediate
The following genes and proteins are key players in the single stranded viral RNA replication via double stranded DNA intermediate pathway, including viral enzymes and host factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Reverse transcriptase (RT) | Catalyzes reverse transcription of viral RNA into dsDNA | Primary target of antiviral drugs; mutations confer resistance |
| Integrase | Mediates integration of viral dsDNA into host genome | Target of integrase strand transfer inhibitors (INSTIs) |
| HBV polymerase | Multifunctional enzyme with reverse transcriptase, DNA polymerase, and RNase H activities | Key drug target for HBV; mutations affect treatment response |
| HBV core protein | Forms capsid; interacts with pregenomic RNA and RT | Essential for capsid assembly and reverse transcription |
| HBV X protein (HBx) | Regulates transcription and cccDNA stability | Implicated in hepatocellular carcinoma; target for functional studies |
| Host RNA polymerase II | Transcribes integrated viral DNA into RNA | Host factor required for viral gene expression; potential target for host-directed therapy |
| LEDGF/p75 (PSIP1) | Tethering factor for HIV integrase to chromatin | Host dependency factor; knockout reduces integration |
| Transportin 3 (TNPO3) | Imports HIV pre-integration complex into nucleus | Host factor; knockdown inhibits infection |
| NUP153 | Nuclear pore protein involved in HIV integration | Host factor; required for nuclear import of viral DNA |
| CPSF6 | Regulates HIV nuclear import and integration site selection | Host factor; knockdown alters integration pattern |
| Cyclophilin A (PPIA) | Chaperone that modulates HIV capsid function | Host factor; affects reverse transcription and infectivity |
| APOBEC3G | Cytidine deaminase that restricts retroviruses | Host restriction factor; counteracted by HIV Vif |
| SAMHD1 | dNTP hydrolase that restricts reverse transcription | Host restriction factor; counteracted by HIV Vpx |
| TRIM5α | Restriction factor that targets retroviral capsids | Host factor; species-specific restriction |
| HBV cccDNA | Persistent episomal DNA form of HBV genome | Key target for curative therapies; quantified by PCR |
| AAV Rep proteins | Regulate AAV RNA processing and replication | Model for RNA processing in ssDNA viruses |
| Kunjin virus NS proteins | Replication complex components for flaviviruses | Model for RNA replication, though not via dsDNA intermediate |
| Tick-borne encephalitis virus helicase | RNA-stimulated ATPase involved in flavivirus replication | Model for helicase mechanism, not directly GO:0039692 |
How Is single stranded viral RNA replication via double stranded DNA intermediate Regulated?
The process of single stranded viral RNA replication via double stranded DNA intermediate is regulated at multiple levels. Viral reverse transcriptase activity can be modulated by host factors such as SAMHD1, which depletes dNTP pools and restricts reverse transcription. Conversely, viral proteins like HIV Vif and Vpx counteract host restriction factors (APOBEC3G and SAMHD1, respectively) to promote efficient reverse transcription. Integration site selection is influenced by host proteins such as LEDGF/p75 and CPSF6, which tether the viral pre-integration complex to chromatin. Transcription of the integrated provirus is regulated by host transcription factors, chromatin remodeling complexes, and viral transactivators such as Tat (HIV) or HBx (HBV). Additionally, epigenetic modifications of the viral DNA, including methylation and histone acetylation, can silence or activate viral gene expression. Understanding these regulatory mechanisms is crucial for developing strategies to control viral replication and latency.
single stranded viral RNA replication via double stranded DNA intermediate and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIV RT | AIDS; drug resistance | Knockout of host factors (e.g., SAMHD1) in CD4+ T cells; point mutations in RT to study resistance |
| HBV polymerase | Chronic hepatitis B; hepatocellular carcinoma | HBV-infected hepatocyte cell lines (HepG2.2.15); CRISPR knockout of cccDNA regulators |
| HIV integrase | AIDS; integration | Knock-in of tagged integrase in proviral clones; knockout of LEDGF/p75 |
| HBx | Hepatocellular carcinoma | HBx transgenic mice; knockout of HBx in HBV genome |
| APOBEC3G | HIV restriction | Overexpression or knockout in T cell lines; point mutation to abrogate Vif counteraction |
HIV/AIDS
HIV uses GO:0039692 to replicate its RNA genome via a dsDNA intermediate that integrates into host CD4+ T cells and macrophages. This leads to progressive depletion of CD4+ T cells and immunodeficiency. Antiretroviral therapy targets reverse transcriptase and integrase, but latent provirus persists, requiring lifelong treatment.
Hepatitis B and Hepatocellular Carcinoma
HBV replicates via a dsDNA intermediate (cccDNA) that persists in hepatocytes. Chronic infection can lead to cirrhosis and hepatocellular carcinoma (HCC). Integration of HBV DNA into the host genome can cause insertional mutagenesis and genomic instability, contributing to HCC. Antiviral drugs suppress replication but rarely cure infection due to cccDNA persistence.
Retroviral Vector Safety in Gene Therapy
Retroviral and lentiviral vectors used in gene therapy rely on GO:0039692 for transduction. However, integration can cause insertional oncogenesis, as observed in early clinical trials. Safer vector designs and integration-deficient vectors are being developed to mitigate this risk.
Emerging Viral Infections
Other retroviruses and pararetroviruses that utilize GO:0039692 can cause zoonotic infections. For example, simian foamy virus and human T-lymphotropic virus (HTLV) establish persistent infections. Understanding their replication mechanisms is important for public health preparedness.
From single stranded viral RNA replication via double stranded DNA intermediate-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a host gene regulate reverse transcription? | CRISPR knockout of candidate gene in permissive cells, followed by HIV or HBV infection and qPCR for viral DNA |
| Does a point mutation in reverse transcriptase confer drug resistance? | Point mutation knock-in in viral reverse transcriptase gene using CRISPR, followed by drug susceptibility assays |
| Can we visualize integration sites? | Knock-in of fluorescent tags into viral integrase or host chromatin markers; imaging and sequencing |
| What is the role of a host factor in cccDNA formation? | Knockout of candidate gene in HBV-infected hepatocytes; quantification of cccDNA by PCR |
| Can we overexpress a restriction factor to block replication? | Overexpression of APOBEC3G or SAMHD1 in target cells; measure viral infectivity |
| Does a viral protein interact with host chromatin? | Knock-in of epitope tags into viral proteins; ChIP-seq and proteomics |
How to Study the single stranded viral RNA replication via double stranded DNA intermediate Process
| Method | What It Measures | Typical Application |
|---|---|---|
| qPCR/digital PCR | Viral DNA intermediates (dsDNA, cccDNA) | Quantify reverse transcription and integration; monitor antiviral therapy |
| RNA-seq | Viral and host transcript levels | Analyze viral gene expression and host response |
| CRISPR knockout screen | Host genes required for viral replication | Identify novel antiviral targets |
| ChIP-seq | Protein-DNA interactions | Map integration sites and chromatin modifications |
| Immunoblotting | Viral and host protein expression | Assess protein levels and processing |
| Luciferase reporter assay | Viral promoter activity | Screen for inhibitors of transcription |
| Fluorescence microscopy | Subcellular localization of viral components | Visualize replication complexes |
| Deep sequencing | Viral quasispecies and mutations | Study drug resistance and evolution |
Quantification of Viral DNA Intermediates
Quantitative PCR (qPCR) and digital PCR are used to measure viral dsDNA intermediates, including integrated provirus and HBV cccDNA. These methods are essential for assessing the efficiency of reverse transcription and integration, and for monitoring antiviral treatment. Southern blotting can also detect integrated viral DNA.
RNA Sequencing and Transcriptome Analysis
RNA-seq can profile viral and host transcripts during GO:0039692. It reveals the abundance of viral genomic RNA, spliced subgenomic RNAs, and host genes whose expression is altered by infection. This approach has been used to study HBV and retroviral transcription.
CRISPR Screens for Host Dependency Factors
Genome-wide CRISPR knockout screens have identified host genes required for HIV and HBV replication, including those involved in reverse transcription and integration. These screens use lentiviral or retroviral vectors to deliver sgRNAs, and selection with viral challenge to enrich for resistant cells.
Imaging and Reporter Assays
Fluorescently tagged viral proteins and DNA dyes allow visualization of viral replication complexes and integration sites. Reporter viruses expressing luciferase or GFP enable high-throughput screening of antiviral compounds and host factors.
How CRISPR Can Be Used to Study GO:0039692 single stranded viral RNA replication via double stranded DNA intermediate
Knockout
CRISPR knockout of host genes is used to identify factors essential for GO:0039692. For example, knockout of SAMHD1 or LEDGF/p75 in cell lines can enhance or reduce HIV reverse transcription and integration, respectively. Knockout of HBV cccDNA regulators in hepatocytes can reveal mechanisms of viral persistence.
Point Mutation
Point mutations can be introduced into viral genes to study drug resistance or enzyme function. For instance, mutations in HIV reverse transcriptase (e.g., K103N) confer resistance to non-nucleoside inhibitors, and CRISPR can be used to engineer these mutations into proviral clones for phenotypic assays.
Knock-in
Knock-in of epitope tags or fluorescent proteins into viral or host genes allows tracking of viral proteins and complexes. Tagging integrase or capsid proteins enables imaging and proteomic analysis of the replication process. Knock-in of reporter genes under viral promoters can quantify transcription.
Overexpression
Overexpression of host restriction factors (e.g., APOBEC3G, TRIM5α) or viral proteins can suppress or enhance GO:0039692. CRISPR activation (CRISPRa) can be used to overexpress endogenous genes to study their effect on viral replication.
How EDITGENE Supports single stranded viral RNA replication via double stranded DNA intermediate Research
Researchers studying single stranded viral RNA replication via double stranded DNA intermediate-related genes often need to determine whether a candidate gene is causally involved in viral replication, integration, or host restriction. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of host and viral factors.
Contact EDITGENE today to design your custom CRISPR model for single stranded viral RNA replication via double stranded DNA intermediate research.
Frequently Asked Questions About single stranded viral RNA replication via double stranded DNA intermediate
What is GO:0039692?
GO:0039692 is a Gene Ontology term for the biological process 'single stranded viral RNA replication via double stranded DNA intermediate', which describes how certain viruses, like HIV and HBV, replicate their RNA genome through a DNA intermediate that integrates into the host genome.
What genes are involved in single stranded viral RNA replication via double stranded DNA intermediate?
Key genes include viral reverse transcriptase, integrase, and HBV polymerase, as well as host factors such as LEDGF/p75, SAMHD1, APOBEC3G, and CPSF6.
Which viruses use GO:0039692 for replication?
Retroviruses (e.g., HIV) and hepadnaviruses (e.g., HBV) are the primary viruses that replicate via this mechanism.
How does reverse transcription work in GO:0039692?
Reverse transcriptase converts the viral RNA genome into double-stranded DNA, which then integrates into the host genome.
Why is GO:0039692 important for drug development?
The reverse transcription and integration steps are targets for antiviral drugs used to treat HIV and HBV infections.
What diseases are associated with GO:0039692?
HIV/AIDS, chronic hepatitis B, and hepatocellular carcinoma are major diseases linked to this replication process.
How can CRISPR be used to study GO:0039692?
CRISPR knockout, knock-in, and point mutation models can be used to dissect the roles of host and viral genes in reverse transcription, integration, and transcription.
What is the role of host RNA polymerase II in GO:0039692?
Host RNA polymerase II transcribes the integrated viral DNA into new viral RNA molecules, which are then packaged into virions.
Can GO:0039692 be targeted for gene therapy?
Yes, retroviral vectors exploit this pathway for gene delivery, but safety concerns regarding insertional mutagenesis require careful vector design.
What methods are used to study GO:0039692?
Common methods include qPCR for viral DNA, RNA-seq for transcripts, CRISPR screens for host factors, and imaging of viral replication complexes.
Conclusion
GO:0039692, single stranded viral RNA replication via double stranded DNA intermediate, is a central replication strategy for retroviruses and hepadnaviruses, with profound implications for human health. The pathway is a validated target for antiviral drugs and a key consideration in gene therapy vector design. Continued research using CRISPR-based models and advanced sequencing will uncover new host dependency factors and mechanisms of viral persistence, paving the way for curative therapies.
References
- 1. Hu J et al.. 2017. Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.. Viruses 9(3) PMID: 28335554
- 2. Qiu J et al.. 2008. Processing of adeno-associated virus RNA.. Front Biosci 13:3101-15 PMID: 17981780
- 3. Westaway EG et al.. 2003. Kunjin RNA replication and applications of Kunjin replicons.. Adv Virus Res 59:99-140 PMID: 14696328
- 4. Brass JR et al.. 2017. Viroid quasispecies revealed by deep sequencing.. RNA Biol 14(3):317-325 PMID: 28027000
- 5. Anindita PD et al.. 2022. Mechanistic insight into the RNA-stimulated ATPase activity of tick-borne encephalitis virus helicase.. J Biol Chem 298(10):102383 PMID: 35987382
- 6. Valenzuela P. 1990. Hepatitis A, B, C, D and E viruses: structure of their genomes and general properties.. Gastroenterol Jpn 25 Suppl 2:62-71 PMID: 2227269
- 8. Kamiya N et al.. 2022. Untying relaxed circular DNA of hepatitis B virus by polymerase reaction provides a new option for accurate quantification and visualization of covalently closed circular DNA.. J Gen Virol 103(2) PMID: 35130138
